View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A Phase 1 Study of Intravenous EGFR-ErbituxEDVSMIT (EEDVSMit) in Children with Recurrent / Refractory Solid or CNS Tumours Expressing Epidermal Growth Factor Receptor (EGFR).
  • Protocol ID
    ECREST
  • Disease
    Disease Type Disease Subtype
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Sydney Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 1
  • Study type
    Treatment
  • Diagnosis stage
    Relapse/refractory
  • Study open date
    08/02/2016
  • Study close date
    N/A
  • Study chair
  • Sponsor
    Sydney Children's Hospital Network
Back to search results